TUCATINIB vs UBROGEPANT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TUCATINIB vs UBROGEPANT: Safety Overview
| Metric | TUCATINIB | UBROGEPANT |
|---|---|---|
| Total FAERS Reports | 6,042 | 2,531 |
| Deaths Reported | 640 | 49 |
| Death Rate | 10.6% | 1.9% |
| Hospitalizations | 1,717 | 145 |
| Average Patient Age | 57.6 yrs | 49.2 yrs |
| % Female Patients | 95.5% | 83.6% |
| FDA Approval Date | Apr 17, 2020 | Dec 23, 2019 |
| Manufacturer | SEAGEN INC. | Allergan, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |